US · guidance
CMS Pub. 100-03, ch. 1, § 160.20
Transfer Factor for Treatment of Multiple Sclerosis
CIM 45-17
Transfer factor is the dialysate of an extract from sensitized leukocytes which increases
cellular immune activity in the recipient. It is not covered as a treatment for multiple
sclerosis because its use for the purpose is still experimental.
History
(Rev. 1, 10-03-03)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
4e0f86faeb9247f075692e5b007ec9c9f5379ef7ee68469fdde86427dddcc5a4
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.